March 2016 | NIH I-Corps |
CrossLife has been selected for the highly competitive NIH I-Corps entrepreneur immersion training program. The goal of the program is to identify customers and markets for our point-of-care dengue diagnostic, and to receive training in entrepreneurship.
In line with the President’s Strategy for American Innovation and following the success of the 2014 pilot cohort, NIH is offering this entrepreneurial training program across 17 Institute/Centers at the NIH and CDC to support NIH/CDC SBIR/STTR funded academic researchers and small businesses to accelerate the translation of innovations from the lab to clinical practice. In 2017, the I-Corps™ at NIH is expanded to offer two cohorts to SBIR/STTR Phase I grantees across 17 Institutes/Centers across the NIH and CDC.
Based on the highly successful NSF I-Corps™ program, the I-Corps at NIH curriculum is designed to provide scientists from NIH SBIR funded companies with real-world, hands-on entrepreneurship training, facilitated by domain experts from the biotech sector.
This program seeks to accelerate the development and commercialization of new products and services arising from projects supported by currently funded NIH/CDC Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) awards. In particular, the I-Corps™ program is designed to support training that will help project teams at NIH- and CDC-funded small businesses overcome key obstacles along the path of innovation and commercialization.
White House Demo Day
“We’re scaling up the National Science Foundation’s successful Innovation Corps program at six more federal agencies so we can help more of our scientists move their ideas out of the lab and into the marketplace.”
– President Obama (August 4, 2015)